Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Allchem Lifescience
Consolidated
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Allchem Lifescience share price
Allchem Lifescience Ltd.
242
0
0
The company is currently not listed and is under IPO, so all the data might not be available.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
10.9%
3 Year
12.13%
5 Year
NA
Profit Growth
1 Year
3.16%
3 Year
19.53%
5 Year
NA
ROE%
1 Year
26.26%
3 Year
33.52%
ROCE %
1 Year
20.86%
3 Year
22.4%
Debt/Equity
1.2479
Price to Cash Flow
0
Interest Cover Ratio
0
CFO/PAT
(5 Yr. Avg.)
0
Strengths
Company has been maintaining healthy ROE of
33.5186
% over the past 3 years.
Company has been maintaining healthy ROCE of
22.3985
% over the past 3 years.
The company has an efficient Cash Conversion Cycle of
0
days.
Limitations
The company has shown a poor revenue growth of
12.1291154800859
% for the Past 3 years.
Company has low Interest coverage ratio of
0
.
The company has a low EBITDA margin of
0
% over the past 5 years.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Sales
108.1
105.72
137.42
152.4
Total Expenditure
83.08
75.61
85.13
86.12
Operating Profit
25.03
30.11
52.29
66.28
Other Income
1.32
0.65
0.65
0.39
Interest
3.55
1.86
6.39
10.6
Depreciation
2.34
2.37
14.26
23.02
Exceptional Items
0
0
0
0
Profit Before Tax
20.45
26.52
32.3
33.06
Tax
6.31
8.54
8.89
8.91
Net Profit
14.14
17.99
23.41
24.15
Adjusted EPS (Rs.)
2.24
2.35
3.06
3.16
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Equity and Liabilities
Share Capital
3.5
4.25
4.25
76.54
Total Reserves
35.08
52.24
75.64
27.46
Borrowings
37.6
81.34
80.36
82.83
Other N/C liabilities
0.7
2.87
6.71
7.95
Current liabilities
46.66
45.98
57.7
77.21
Total Liabilities
123.53
186.68
224.65
272
Assets
Net Block
19.64
75.5
145.35
145.58
Capital WIP
38.29
54.07
12.16
13.61
Intangible WIP
0
0
0
0
Investments
0
0
0
0
Loans & Advances
0.46
0.46
0.82
1.83
Other N/C Assets
0
0
0
0
Current Assets
65.13
56.65
66.32
110.99
Total Assets
123.53
186.68
224.65
272
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2024
Mar 2025
Profit from operations
32.3
33.07
Adjustment
20.58
33.47
Changes in Assets & Liabilities
-5.66
-52.14
Tax Paid
-6.5
-5.23
Operating Cash Flow
40.72
9.17
Investing Cash Flow
-42.16
-24.8
Financing Cash Flow
1.4
15.69
Net Cash Flow
-0.04
0.06
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
Allchem Lifescience files DRHP with SEBI
17 Mar, 2:46 PM
Last Updated on:
Brief about Allchem Lifescience
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X